<img alt="" height="1" width="1" />
Keryx cancer treatment gets faster FDA review
Keryx Biopharmaceuticals Inc. and AEterna Zentaris Inc. said Monday regulators have given a "fast track" designation to the drug candidate perifosine as a potential treatment for refractory advanced colorectal cancer. The designation allows the Food ...
Keryx, Aeterna rocket on FDA moveMarketWatch
Keryx Biopharma&#39;s Colorectal Cancer Drug Granted Fast Track Designation By FDA ...RTT News
Oral cancer treatment fast-trackedMontreal Gazette
MSN Money -Reuters Canada -ONN.tv
all 72 news articles &raquo;